Friday, July 20, 2018
 
 
Company News: Page (1) of 1 - 07/12/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
SGF Atlanta Physicians Recognized as Top Doctors for Infertility by Atlanta Magazine
 
(July 12, 2018)
SGF Atlanta Physicians Recognized as Top Doctors for Infertility by Atlanta Magazine

SGF Atlanta is proud to announce that their three physicians Drs. Mark Perloe, Anne Namnoum, and Desireé McCarthy-Keith have been named Atlanta Magazine's Top Docs for Infertility. This recognition is voted on by physician peers in various fields of medicine. As leaders in reproductive medicine, SGF Atlanta physicians are committed to providing exceptional fertility care at a practice that is at the forefront of cutting-edge reproductive technology.

The top doctors list is compiled by Castle Connolly Medical Ltd, which guides consumers to America's top doctors and top hospitals. Castle Connolly's established nomination survey, research, screening, and selection process, under the direction of an M.D., involves many hundreds of thousands of physicians as well as academic medical centers, specialty hospitals, and regional and community hospitals all across the nation. Castle Connolly's physician-led team of researchers follows a rigorous screening process to select top doctors on both the national and regional levels. Careful screening of doctors' educational and professional experience is essential before final selection is made among those physicians most highly regarded by their peers.

I am honored and humbled to be recognized as a top doctor in my field by my physician peers," said Mark Perloe, M.D.



I feel privileged to be part of a practice that is committed to providing highly personalized care for each person's unique situation," said Anne Namnoum, M.D.

We are proud to be recognized in the community for our work in helping to build families. We look forward to another year of possibilities, and helping even more people achieve their dream of parenthood," said Desireé McCarthy-Keith, M.D.

SGF Atlanta currently has three locations in Atlanta, Buckhead, and Alpharetta. The practice was formed in July 2017 when Georgia Reproductive Specialists and Shady Grove Fertility, which has locations throughout Maryland, Pennsylvania, Virginia, Washington, D.C., and Florida announced their merger. By combining the successful clinical, scientific, and operational approaches, the merger offered an exceptional opportunity to provide enhanced fertility services and unique financial programs to the Atlanta community.

To learn more, schedule an appointment at any one of SGF Atlanta's three locations by calling 1-888-761-1967.

About Shady Grove Fertility Atlanta
SGF Atlanta, formerly Georgia Reproductive Specialists (GRS), is part of the Shady Grove Fertility (SGF) international network of state-of-the-art infertility care and IVF centers, offering patients individualized care, innovative financial options, and pregnancy rates among the highest in the United States. Call 1-888-761-1967 or visit ShadyGroveFertility.com

Read the full story at https://www.prweb.com/releases/2018/07/prweb15623830.htm.


Page: 1


Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research

    Cancer
  • Mesothelioma is a Deadly Cancer and its Completely Preventable
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
  • Omega-3 Market to Reach US$ 16.37 Bn by 2023, Globally - QYResearch.com
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines